PlainRecalls
FDA Drug Low Class III Terminated

Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient, DMF No. 15931; Manufactured by: Lupin Limited, Unit-1, 198-202, New Industrial Area No. 2, Dist. Raisen, Mandideep-462 046, (Madhya Pradesh) India; Regd. Office: 159, CST Road Kalina, Santacruz (E), Mumbai- 400 098, (Maharashtra) India.

Reported: June 8, 2016 Initiated: March 11, 2016 #D-0955-2016

Product Description

Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient, DMF No. 15931; Manufactured by: Lupin Limited, Unit-1, 198-202, New Industrial Area No. 2, Dist. Raisen, Mandideep-462 046, (Madhya Pradesh) India; Regd. Office: 159, CST Road Kalina, Santacruz (E), Mumbai- 400 098, (Maharashtra) India.

Reason for Recall

CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications.

Details

Units Affected
741.171 kg
Distribution
Nationwide and Puerto Rico
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient, DMF No. 15931; Manufactured by: Lupin Limited, Unit-1, 198-202, New Industrial Area No. 2, Dist. Raisen, Mandideep-462 046, (Madhya Pradesh) India; Regd. Office: 159, CST Road Kalina, Santacruz (E), Mumbai- 400 098, (Maharashtra) India.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 741.171 kg.
Why was this product recalled?
CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 8, 2016. Severity: Low. Recall number: D-0955-2016.